Effects of Labetalol on Hemodynamic Parameters and Soluble Biomarkers of Inflammation in Acute Coronary Syndrome in Patients With Active Cocaine Use

Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30303, USA.
Journal of Cardiovascular Pharmacology and Therapeutics (Impact Factor: 2.09). 03/2010; 15(1):47-52. DOI: 10.1177/1074248409358409
Source: PubMed


Cocaine use is associated with increased cardiovascular mortality and can promote acute coronary syndrome (ACS). Use of beta-blockers is controversial in patients who use cocaine, and the safety and efficacy of these medications in ACS in patients actively using cocaine is unknown. We enrolled 90 patients with ACS and positive urine drug screen for cocaine. Patients received standard ACS therapy plus either labetalol (n = 60) or diltiazem (n = 30). Blood pressure and heart rate were measured at baseline and 48 hours. Levels of serum CD40 ligand, interleukin (IL)-6, and choline at baseline and 48 hours were determined. There were no baseline differences in hemodynamics or serum levels of inflammatory markers between the labetalol and diltiazem groups. Both groups experienced a significant and equivalent decrease in BP and HR at 48 hours compared with baseline. At 48 hours of treatment, there were significant decreases of 17% in CD40 ligand (P < .005) and 16% in IL-6 (P < .005) but no change in choline in the diltiazem group. Furthermore, in the labetalol group, there were significant differences of 30% in CD40 ligand (P < .005 time and group comparison), 22% in IL-6 (P < .005 time and group comparison), and 18% in choline (P < .005 time and group comparison). There were no adverse events during hospitalization in any patients who received labetalol. In conclusion, labetalol appears to be safe in cocaine-associated ACS. Furthermore, labetalol provides a beneficial hemodynamic response and, in comparison to diltiazem, potentiates an anti-inflammatory vascular response in this setting.

21 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: We describe a new method of polarization sensing using a resonant cavity enhanced (RCE) photodetector vertically integrated with a conventional detector. Establishing polarization selectivity in a compact semiconductor device structure is strongly desirable for many applications, ranging from imaging arrays to magneto-optic data storage. In imaging, there is a compelling motivation to study polarization vision. Beside the color and intensity of light, polarization may underlie additional information in an image
    Lasers and Electro-Optics Society Annual Meeting, 1996. LEOS 96., IEEE; 12/1996
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The binding of CD40 ligand (CD40L) to CD40 stimulates inflammatory processes including the release of proinflammatory cytokines and the expression of adhesion molecules implying a role in atherosclerosis. Patients exhibiting hypercholesterolemia, unstable angina, or acute myocardial infarction present with increased CD40L levels. Novel data suggest that elevated soluble CD40L levels not only represent a risk factor for cardiovascular disease but also predict future adverse events, especially in patients with acute coronary syndromes (ACS). Examination of the potential role of the genetic variability on CD40/CD40L genes in ACS, as regards the regulation of CD40L, appears to be of great interest. Moreover, several therapeutic approaches such as statins, antihypertensive agents, and antiplatelet agents have been suggested as potential modulators of CD40L levels anticipating a positive impact on the outcomes of patients with ACS. Whether specific agents target the CD40/CD40L system as well as its pathogenic role in ACS remains to be elucidated by large-scale studies in the future.
    Trends in cardiovascular medicine 07/2010; 20(5):153-64. DOI:10.1016/j.tcm.2010.12.004 · 2.91 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cardiac ischemia in children is usually not an isolated disease in an otherwise normally formed coronary artery but is part of more complex congenital or acquired diseases. Although cardiac ischemia is not a frequent occurrence, it must be recognized as a serious, life-threatening event. This article lists and characterizes major causes of cardiac ischemia in children, describes signs and symptoms of each, and provides therapeutic considerations.
    Pediatric Clinics of North America 12/2010; 57(6):1261-80. DOI:10.1016/j.pcl.2010.09.007 · 2.12 Impact Factor
Show more

Similar Publications